Lars Borgström Consulting has joined the Medicon Valley Inhalation Consortium (MVIC), bringing the group of companies involved in inhalation product development in the Skåne-Copenhagen region to 14 members. Borgström, the first recipient of RDD’s Charles G. Thiel award, recently retired from AstraZeneca and is offering “advice on clinical aspects of inhaled medication with a focus on early clinical pharmacology: lung deposition, bioequivalence, and in vitro/in vivo correlations.”
According to the MVIC’s Orest Lastow, the 2nd Medicon Valley Inhalation Symposium has been scheduled for October 16, 2013, and registration will open in the second quarter of the year. Lastow reports that the first symposium, held in Lund, Sweden on October 17, 2012, attracted 90 delegates, 15 speakers, 20 exhibitions, and 10 sponsors.
